Current Studies

At present, approximately 30 of our own clinical studies on neurological and (neuro-) psychiatric diseases are being carried out at the NeuroCure Clinical Research Center (NCRC) of the Charité - Universitätsmedizin Berlin.

The studies listed here represent only a selection of the many diagnostic and therapeutic studies offered at the NCRC. In addition to our own studies, we also take part in studies carried out by pharmaceutical companies (e.g. studies on Fingolimod (Novartis), Laquinimod (TEVA Pharma), Copaxone (TEVA Pharma), Masitinib (AB Science), Belimumab (GlaxoSmithKline), IgPro20 (CSL Behring GmbH), register studies (Biomarin) and CFZ533 CD40-Antikörper (Novartis)).

Studies on Multiple Sclerosis (a selection):

Studies on Neuromyelitis Optica (NMO):

Studies on Susac's Syndrome:

Studies on Stroke (a selection):

Studies on Myasthenia Gravis (a selection):

Studies on Chronic Inflammatory Demyelinating Polyneuropathy CIDP (a selection):

Studies on Developmental Disorders of the Nervous System (e.g. Epilepsy) (a selection):

Studies on Mild Cognitive Impairment (MCI) and Alzheimer's Disease (a selection):

Studies on brain functions

Studies on psychiatric diseases